Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The decision to start semaglutide therapy isn't based on hitting a specific weight milestone—it depends on your body mass index (BMI), existing weight-related health conditions, and metabolic readiness. Research shows that adults with a BMI of 30 or higher, or those with a BMI of 27+ who have obesity-related complications like type 2 diabetes or hypertension, benefit most from GLP-1 receptor agonist therapy.
BMI Thresholds for Semaglutide Eligibility
Body mass index serves as the primary screening tool for semaglutide candidacy, though it's not the only factor. The FDA-approved indication for semaglutide (Ozempic, Wegovy) targets individuals with a BMI of 30 kg/m² or higher, classifying them as obese by clinical standards. For those with a BMI between 27 and 30, semaglutide may still be appropriate if you have at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea.
BMI is calculated by dividing your weight in kilograms by your height in meters squared (kg/m²). A person who is 5'10" and weighs 215 pounds has a BMI of approximately 31, placing them in the eligible range. However, BMI alone doesn't capture muscle mass, bone density, or visceral fat distribution—all factors that influence metabolic health and treatment response.
Health Conditions That Support Semaglutide Treatment
Beyond BMI, the presence of obesity-related medical conditions significantly strengthens the case for starting semaglutide therapy. Type 2 diabetes, cardiovascular disease, hypertension, fatty liver disease, and obstructive sleep apnea all represent serious health risks that GLP-1 medications help address. Clinical trials demonstrate that semaglutide reduces cardiovascular events and improves glycemic control in patients with these comorbidities, making treatment medically justified even at lower BMI levels.
Your personal medical history also matters. If you have a family history of heart disease or diabetes, have experienced weight regain after previous dieting attempts, or struggle with hunger hormones and appetite regulation, these factors indicate that your body may benefit from semaglutide's mechanism of action on the hypothalamus and gut-brain signaling pathways.
How PlexusDx Evaluates Your Readiness for Semaglutide
PlexusDx takes a precision health approach beyond standard BMI cutoffs, evaluating your complete metabolic and genetic profile before recommending compounded semaglutide injection. During your initial consultation, our team reviews your weight history, current medications, existing health conditions, and lifestyle factors to determine if GLP-1 therapy aligns with your goals and medical needs. This personalized assessment ensures you start the right medication at the right dose for your body.
After your first month of treatment, PlexusDx offers the Precision Peptide Genetic Test—a $99 add-on that maps 14 metabolic pathways and 49 peptides involved in appetite regulation, energy expenditure, and weight control. This test identifies your genetic predispositions related to key variants in the GLP1R, GIPR, FTO, and MC4R genes, allowing PlexusDx clinicians to refine your treatment strategy based on your unique biochemistry. Knowledge of these genetic insights helps predict your response to semaglutide and whether dose optimization or medication switching may benefit you over time.
Starting Semaglutide: Price and Access Through PlexusDx
PlexusDx compounded semaglutide injection starts at $149 per month—a flat rate that remains unchanged as your dose increases. Unlike some GLP-1 programs that charge flat per-compound pricing, PlexusDx commits to transparent, commitment-based pricing across three tiers, meaning your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies and are available nationwide without insurance, membership fees, or prior authorization requirements.
Treatment is HSA and FSA eligible, making it accessible for those using tax-advantaged health savings accounts. PlexusDx serves all 50 states and handles pharmacy logistics directly, delivering your compounded semaglutide injections on a schedule that matches your clinical protocol. Whether you're a candidate based on BMI alone or have additional health conditions supporting treatment, PlexusDx offers a straightforward path to GLP-1 therapy with genetics-informed personalization.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What weight do I need to be to qualify for semaglutide through PlexusDx?
PlexusDx doesn't have a minimum weight requirement. Instead, eligibility is based on BMI (30 or higher, or 27+ with weight-related health conditions), medical history, and your clinician's assessment. Your actual weight matters less than your metabolic health profile and whether semaglutide addresses your specific risk factors.
Can I start semaglutide if my BMI is 28 but I have type 2 diabetes?
Yes. Clinical evidence supports semaglutide use in patients with a BMI of 27 or higher who have obesity-related comorbidities like type 2 diabetes. PlexusDx evaluates your complete health picture, and diabetes combined with overweight status meets the threshold for compounded semaglutide injection therapy.
How much does PlexusDx compounded semaglutide cost per month?
Compounded semaglutide injection through PlexusDx starts at $149 per month on the first tier, with pricing that remains flat regardless of dose level. This transparent, non-escalating pricing applies across all three commitment options, and treatment is HSA/FSA eligible with no insurance or membership fees required.
What is the Precision Peptide Genetic Test, and does it help predict semaglutide response?
The Precision Peptide Genetic Test is a $99 add-on available after your first month of PlexusDx treatment that analyzes 49 peptides across 14 metabolic pathways, including key variants in GLP1R, GIPR, FTO, and MC4R genes. This test reveals your genetic predispositions for appetite control and energy metabolism, helping clinicians predict your semaglutide response and optimize your treatment strategy.
Are PlexusDx compounded medications FDA-approved?
PlexusDx compounded semaglutide and other GLP-1 medications are not FDA-approved as compounded products; they are prepared by licensed 503A compounding pharmacies under federal regulations allowing pharmacists to compound medications for individual patients. The active pharmaceutical ingredients themselves are FDA-approved, and 503A compounding provides legal, regulated access to these medications.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Mounjaro Better Than Wegovy for Weight Loss?
Understanding Ozempic Clearance: How Long Does It Take Ozempic To Leave The Body?